Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

JOHNSON & JOHNSON

(JNJ)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Public Citizen: Victory for Investors - SEC Won't Stop Johnson, Johnson From Rejecting Shareholder Arbitration Proposal That Might Be Illegal

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/12/2019 | 09:32am EST

WASHINGTON, Feb. 11 -- Public Citizen issued the following statement by Lisa Gilbert, vice president of legislative affairs:

Today, the U.S. Securities and Exchange Commission (SEC) issued the "no action" letter to Johnson & Johnson that Public Citizen called for (PDF) in December. The letter states that the SEC will take no action against Johnson & Johnson if the company excludes from its proxy materials a shareholder proposal that would force investor disputes into mandatory arbitration. The SEC's staff made this determination after the New Jersey attorney general asserted that the arbitration proposal would violate state law.

"The U.S. Securities and Exchange Commission (SEC) did the right thing by deciding not to take action against Johnson & Johnson and protecting investors against forced arbitration.

"While this is a significant victory, investors need real and lasting protections, which is why Congress must immediately ban forced arbitration.

"This issue will not go away because corporate interests will continue to hound the SEC to restrict the rights of investors. We must ensure that the SEC continues to allow investors to hold corporate wrongdoers accountable."

© 2019 Targeted News Service, source News Service

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on JOHNSON & JOHNSON
09:43aMARKETS RIGHT NOW : Stocks open lower on Wall Street
AQ
08:28aJOHNSON & JOHNSON : US investigating Johnson & Johnson over baby powder's Safety
AQ
02:48aJOHNSON & JOHNSON : J&J Gets Subpoenas Related To Talc
DJ
02/20JOHNSON & JOHNSON : DOJ, SEC Subpoena J&J for Talc Safety Information
DJ
02/20JOHNSON & JOHNSON : MANAGEMENT'S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATION..
AQ
02/19JOHNSON & JOHNSON : Statement on Johnson & Johnson's Commitment to TB in India
AQ
02/19JOHNSON & JOHNSON : NHIF strikes deal to buy cancer drug at half price
AQ
02/18JOHNSON & JOHNSON : Innovation Names Winners of Inaugural Champions of Science -..
AQ
02/16JOHNSON & JOHNSON : Refractive Index Measurement System for a Contact Lens in a ..
AQ
02/15JOHNSON & JOHNSON : to Participate in the 8thAnnual SVB Leerink Global, Healthca..
AQ
More news
Financials ($)
Sales 2019 81 061 M
EBIT 2019 25 952 M
Net income 2019 19 844 M
Finance 2019 1 900 M
Yield 2019 2,78%
P/E ratio 2019 18,66
P/E ratio 2020 16,71
EV / Sales 2019 4,49x
EV / Sales 2020 4,19x
Capitalization 366 B
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 144 $
Spread / Average Target 5,5%
EPS Revisions
Managers
NameTitle
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Charles O. Prince Independent Director
William David Perez Independent Director
Anne M. Mulcahy Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON5.15%365 688
PFIZER-2.41%244 760
ROCHE HOLDING LTD.13.68%237 660
NOVARTIS7.90%231 060
MERCK AND COMPANY3.95%206 548
ELI LILLY AND COMPANY5.54%129 936